On September 1, Shanghai Fosun Pharmaceutical (02196) spent HKD 4.2784 million to repurchase 264,000 shares.
Fosun Pharma (02196) announced that on September 1, 2026, the company spent HKD 4.2784 million to repurchase 264,000 shares, with a repurchase price of HKD 16.07-16.28 per share.
Shanghai Fosun Pharmaceutical (02196) announced that on September 1, 2026, the company spent HKD 4.2784 million to repurchase 264,000 shares, with a repurchase price ranging from HKD 16.07 to HKD 16.28 per share.
Related Articles
QUNABOX GROUP (00917) spent HKD 910,100 on September 1 to repurchase 100,000 shares.
CSPC PHARMA (01093): SYS6010 has been included again in the list of breakthrough therapy varieties by the National Medical Products Administration of China for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma.
Zhongman Petroleum And Natural Gas Group Corp., Ltd. (603619.SH): Zhu Fengxue plans to reduce his stake by no more than 1.2%.
QUNABOX GROUP (00917) spent HKD 910,100 on September 1 to repurchase 100,000 shares.
CSPC PHARMA (01093): SYS6010 has been included again in the list of breakthrough therapy varieties by the National Medical Products Administration of China for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma.
Zhongman Petroleum And Natural Gas Group Corp., Ltd. (603619.SH): Zhu Fengxue plans to reduce his stake by no more than 1.2%.
RECOMMEND
